FTC Reports Significant Growth in Flavored E-Cigarette Sales

Oct.12.2022

US FTC report shows flavored e-cigarette sales have significantly increased in US market.

The US Federal Trade Commission (FTC) has recently released a report on the sales and advertising of e-cigarettes, revealing a significant increase in flavored e-cigarette sales in the US market.

Since 1967, the US Federal Trade Commission has been reporting on the sales of tobacco products every year. Last year, the organization expanded its research scope to include electronic cigarettes and published its first report on the subject.

Translated from "Tobacco Industry News

#North America #United States #Traditional tobacco #Legislation #E-cigarette #E-cigarettes and Tobacco #Flavored tobacco and nicotine products #Report #E-cigarettes with Flavors

This document has been generated through artificial intelligence translation and is provided solely for the purposes of industry discourse and learning. Please note that the intellectual property rights of the content belong to the original media source or author. Owing to certain limitations in the translation process, there may be discrepancies between the translated text and the original content. We recommend referring to the original source for complete accuracy. In case of any inaccuracies, we invite you to reach out to us with corrections. If you believe any content has infringed upon your rights, please contact us immediately for its removal.

China Tobacco Regulation Shift：Policy Updates and Market Impact

China Tobacco Regulation Shift：Policy Updates and Market Impact

Kansas Senate approves tougher vape rules to target unlicensed products and child-directed ads

Kansas Senate approves tougher vape rules to target unlicensed products and child-directed ads

The Kansas Senate approved Senate Bill 355 on Wednesday, aiming to crack down on unlicensed vaping products and eliminate advertisements geared toward children. The bill, backed by major tobacco companies, would impose the same licensing and advertising requirements on e-cigarettes as other nicotine products and require every e-cigarette manufacturer doing business in Kansas to obtain a license, with a $2,500 application fee.

Feb.13 by 2FIRSTS.ai

Myanmar announces ban on e-cigarettes, covering imports/exports, sales, possession and use

Myanmar announces ban on e-cigarettes, covering imports/exports, sales, possession and use

Myanmar’s Ministry of Health said it has received cabinet authorization to enforce an e-cigarette ban under the Essential Supplies and Services Law, listing prohibited acts including the import, export, sale, possession, storage, carrying, distribution and use of vaping products.

Feb.26 by 2FIRSTS.ai

China Tobacco Annual Meeting Flags “New Growth Drivers” for 2026: Cigarette Innovation, Domestic Cigars, Overseas Business and Multi-Purpose Use

China Tobacco Annual Meeting Flags “New Growth Drivers” for 2026: Cigarette Innovation, Domestic Cigars, Overseas Business and Multi-Purpose Use

China’s tobacco authorities used their annual industry meeting in Beijing to outline new growth drivers for 2026, highlighting cigarette innovation, domestic cigars, overseas business expansion and multi-purpose tobacco applications.

France’s ANSES warns vaping carries health risks, urges limiting e-cigarette use to smoking cessation

France’s ANSES warns vaping carries health risks, urges limiting e-cigarette use to smoking cessation

France’s National Agency for Food, Environmental and Occupational Health & Safety (ANSES) says vaping poses health risks because users inhale toxic or harmful substances, even if e-cigarettes are generally considered less harmful than cigarettes.

Feb.04 by 2FIRSTS.ai

Puerto Rico House Files P.C. 1070 to Ban Flavored Vaping Product Sales to Under-21s

Puerto Rico House Files P.C. 1070 to Ban Flavored Vaping Product Sales to Under-21s

According to a statement from the Puerto Rico House of Representatives, House Speaker Carlos Méndez and Rep. Pedro Julio Santiago announced the filing of House Bill 1070 (P.C. 1070), which would prohibit sales to people under 21 of vaping devices, liquids, or cartridges featuring a flavor and/or aroma other than nicotine.

Jan.29 by 2FIRSTS.ai

Small ENDS Manufacturers Press FDA on Abuse Liability Standards as Agency Defines Pharmacological Review Framework

Small ENDS Manufacturers Press FDA on Abuse Liability Standards as Agency Defines Pharmacological Review Framework

At the third session of its PMTA roundtable, the FDA outlined its framework for assessing abuse liability in ENDS products, emphasizing the role of nicotine pharmacokinetics and product-specific data in APPH determinations. Small manufacturers questioned the high cost of clinical PK studies and the absence of defined numeric thresholds, while raising bridging strategies and PBPK modeling as potential alternatives.

Related Topics

News

Related Read

Kansas Senate approves tougher vape rules to target unlicensed products and child-directed ads

Kansas Senate approves tougher vape rules to target unlicensed products and child-directed ads

Myanmar announces ban on e-cigarettes, covering imports/exports, sales, possession and use

Myanmar announces ban on e-cigarettes, covering imports/exports, sales, possession and use

China Tobacco Annual Meeting Flags “New Growth Drivers” for 2026: Cigarette Innovation, Domestic Cigars, Overseas Business and Multi-Purpose Use

China Tobacco Annual Meeting Flags “New Growth Drivers” for 2026: Cigarette Innovation, Domestic Cigars, Overseas Business and Multi-Purpose Use

France’s ANSES warns vaping carries health risks, urges limiting e-cigarette use to smoking cessation

France’s ANSES warns vaping carries health risks, urges limiting e-cigarette use to smoking cessation

Puerto Rico House Files P.C. 1070 to Ban Flavored Vaping Product Sales to Under-21s

Puerto Rico House Files P.C. 1070 to Ban Flavored Vaping Product Sales to Under-21s

Small ENDS Manufacturers Press FDA on Abuse Liability Standards as Agency Defines Pharmacological Review Framework

Small ENDS Manufacturers Press FDA on Abuse Liability Standards as Agency Defines Pharmacological Review Framework